Magnetically actuated glaucoma drainage device for regulating intraocular pressure after implantation

Pereira ICF, van Mechelen RJS, Wyss HM, Pinchuk L, Beckers HJM, den Toonder JMJ.

2023
Microsyst Nanoeng.

Therapeutic Area

Glaucoma
Technology

Drug Delivery

Affiliations

5600MB Eindhoven, The Netherlands Microsystems, Department of Mechanical Engineering, Eindhoven University of Technology; 5600MB Eindhoven, The Netherlands Institute for Complex Molecular Systems (ICMS), Eindhoven University of Technology; 6202AZ Maastricht, The Netherlands University Eye Clinic Maastricht, Maastricht University Medical Centre+ (MUMC+); InnFocus, Inc., a Santen Company, Miami, Florida 33186 USA; Miami, Florida 33136 USA Ophthalmic Biophysics Center, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine.

Related Publications

An Exploratory Study of Machine Learning-Based Open-Angle Glaucoma Detection Using Specific Autoantibodies

Takada N., Ishikawa M., Ninomiya T., Izumi Y., Sato K., Kunikata H., Yokoyama Y., Tsuda S., Fukuda E., Yamaguchi K., Ono C., Kirihara T., Shintani C., Hanyuda A., Goshima N., Zorumski C.F., NakazawaT.

Relaxation of Precontracted Ciliary Artery and Ciliary Muscle In Vitro by Kinin Peptides: Relevance to Retinal Blood Flow and Intraocular Pressure Regulation

Sharif N.A., Kulkarni-Chitnis M., Okolie A., Chaudhry S.D., Njie-Mbye Y.F., Ohia S.E.

The Role of EP3 Agonism in Intraocular Pressure-Lowering by Sepetaprost, a Novel Dual Agonist of FP and EP3 Receptors, in Monkeys

Maki K., Kimura E., Yamamoto Y., Fuwa M., Toris C.B., Fan S., Shimazaki A., Kato M.

View all Glaucoma publications